C07F 9/06
Without p—c bonds
Official title: without P—C bonds
C07F9/06 (Without p—c bonds) appears on 4,682 US grants and 3,046 published applications in this corpus.
Search patents in C07F- Granted patents
- 4,682
- Published applications
- 3,046
- Assignees
- 1,862
- Inventors
- 9,204
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 188 | 0 |
| 1977 | 138 | 0 |
| 1978 | 145 | 0 |
| 1979 | 91 | 0 |
| 1980 | 115 | 0 |
| 1981 | 107 | 0 |
| 1982 | 68 | 0 |
| 1983 | 77 | 0 |
| 1984 | 69 | 0 |
| 1985 | 106 | 0 |
| 1986 | 72 | 0 |
| 1987 | 69 | 0 |
| 1988 | 78 | 0 |
| 1989 | 79 | 0 |
| 1990 | 61 | 0 |
| 1991 | 73 | 0 |
| 1992 | 88 | 0 |
| 1993 | 94 | 0 |
| 1994 | 66 | 0 |
| 1995 | 78 | 0 |
| 1996 | 86 | 0 |
| 1997 | 93 | 0 |
| 1998 | 131 | 0 |
| 1999 | 107 | 0 |
| 2000 | 83 | 0 |
| 2001 | 91 | 17 |
| 2002 | 96 | 91 |
| 2003 | 91 | 96 |
| 2004 | 70 | 121 |
| 2005 | 44 | 118 |
| 2006 | 68 | 130 |
| 2007 | 73 | 103 |
| 2008 | 64 | 108 |
| 2009 | 69 | 90 |
| 2010 | 86 | 142 |
| 2011 | 91 | 123 |
| 2012 | 105 | 114 |
| 2013 | 90 | 125 |
| 2014 | 116 | 141 |
| 2015 | 110 | 135 |
| 2016 | 109 | 135 |
| 2017 | 95 | 141 |
| 2018 | 126 | 166 |
| 2019 | 116 | 147 |
| 2020 | 123 | 141 |
| 2021 | 107 | 122 |
| 2022 | 87 | 120 |
| 2023 | 85 | 119 |
| 2024 | 86 | 113 |
| 2025 | 80 | 106 |
| 2026 | 42 | 82 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Biosynthesis of chemically diversified non-natural terpene products6 Oct 2026US 12,753,423 B2Board of Trustees of Michigan State University
- Polyhydroxylated cyclopentane derivatives and methods of use29 Sep 2026US 12,747,257 B2Sanegene Bio USA Inc.
- Organic compound, perovskite precursor solution, perovskite film, perovskite cell, and electric apparatus29 Sep 2026US 12,751,201 B2Contemporary Amperex Technology Co., Limited
- Process for preparing a phosphoramidite and further reaction thereof to the monophosphite22 Sep 2026US 12,741,979 B2Evonik Oxeno GmbH
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Hydrocarbon terminal group-containing compound, surface treatment agent, and article8 Oct 2026US 2026/0308392 A1Shin-Etsu Chemical Co., Ltd.
- Lipids and nanoparticle formulations thereof1 Oct 2026US 2026/0295080 A1Arcturus Therapeutics, Inc.
- Additives for Thermal Management Fluid and Thermal Management Fluid Compositions Including Same1 Oct 2026US 2026/0297410 A1SK Innovation Co., Ltd.
- Novel phosphate compounds and process for preparation thereof17 Sep 2026US 2026/0272959 A1
Most cited
By later US patents
- Synthetic phosphatidyl cholines useful in forming liposomes664US 4,485,045 AResearch Corporation · 1984
- Bead linkers for immobilizing nucleic acids to solid supports600US 5,900,481 ASequenom, Inc. · 1999
- Oligonucleotides with selectably cleavable and/or abasic sites574US 5,367,066 AChiron Corporation · 1994
- Process for the preparation of oligonucleotides515US 4,725,677 ABiosyntech GmbH · 1988
- Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides421US 5,567,811 AAmersham International plc · 1996